Introduction
============

Coronary artery disease (CAD) remains one of the most common causes of morbidity and mortality globally, with an increased prevalence predicted in the near future ([@b1-mmr-18-03-2789]). The occurrence of CAD events is primarily due to crosstalk between genetic and environmental factors ([@b2-mmr-18-03-2789]). A number of risk factors of CAD have been identified, including smoking, obesity and family history ([@b3-mmr-18-03-2789]). Available treatment options primarily include lifestyle alterations, medical treatment and surgical interventions, which are chosen depending on comorbidities and the preferences of the individual patient ([@b4-mmr-18-03-2789]). Prevention and treatment of this disease remains a daunting task. Therefore, further research is required to elucidate the underlying biological features for the development of more adequate therapy for patients.

The rapid prevalence of high-throughput microarray technologies has facilitated identification of genome variations in diseases, contributing to a deeper understanding of pathogenesis and the development of promising biomarkers ([@b5-mmr-18-03-2789],[@b6-mmr-18-03-2789]). Such technologies have been applied to investigate the underlying mechanisms of CAD. Ren *et al* ([@b7-mmr-18-03-2789]) identified a circulating micro (mi)RNA signature for CAD using co-expression network analyses on miRNA array data. In addition, a study of genomic DNA methylation profiling in patients with CAD was conducted ([@b8-mmr-18-03-2789]). Furthermore, Liu *et al* ([@b9-mmr-18-03-2789]) performed a secondary analysis using a weighted gene co-expression network (WGCNA) on microarray data of CAD samples (dataset no. GSE23561), which were downloaded from the Gene Expression Omnibus (GEO) database. It was identified that the glucose-6-phosphate 1-dehydrogenase, protein S100-A7 and hypertrophic cardiomyopathy pathways were involved in CAD ([@b9-mmr-18-03-2789]). However, this previous study had the limitation of sample size (six CAD samples and nine normal samples).

Therefore, four microarray datasets of CAD from the GEO database were included in the present study. WGCNA was used to construct a co-expression network and the highly preserved modules in the four datasets were determined. The MetaDE method in R language, which is capable of conducting 12 primary meta-analysis methods ([@b10-mmr-18-03-2789]), has been utilized for the detection of differentially expressed genes (DEGs) in a number of diseases, including gastric cancer ([@b11-mmr-18-03-2789]) and colorectal cancer ([@b12-mmr-18-03-2789]). In the present study, the DEGs with significant consistency across all four datasets were selected using the MetaDE method and subsequently compared with the genes in the highly preserved WGCNA modules. Subsequently, the overlapping genes were used to construct a protein-protein interaction (PPI) network, followed by functional analysis of the genes in the network. The in-depth analysis conducted in the present study may provide novel insights into the pathogenesis of CAD.

Materials and methods
=====================

### Microarray data

Microarray data for CAD were searched in NCBI GEO (<http://www.ncbi.nlm.nih.gov/geo/>). Inclusion criteria were: i) The dataset belonged to a gene expression profile; ii) samples in the dataset were collected from blood; iii) the samples included patients and healthy controls; iv) the dataset was based on human gene expression profiles; and v) the sample number was ≥20. A total of four datasets, GSE12288 (n=222; CAD, 112; control, 110) ([@b13-mmr-18-03-2789]), GSE20680 (n=139; CAD, 87; control, 52) ([@b14-mmr-18-03-2789]), GSE20681 (n=198; CAD, 99; control, 99) ([@b15-mmr-18-03-2789]) and GSE42148 (n=24; CAD, 13; control, 11; <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42148>) that met the criteria were included in the present study ([Table I](#tI-mmr-18-03-2789){ref-type="table"}).

### Data preprocessing

Raw data in CEL files from GSE12288 were downloaded from the Affy platform (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL96>) and subsequently converted into gene symbols under pretreatment. The median method was used to fill in the missing values, the MicroArray Suite method to complete background correction, and the quantiles method to normalize the data, using oligo 1.41.1 in R3.3.1 language (<http://www.bioconductor.org/packages/release/bioc/html/oligo.html>) ([@b16-mmr-18-03-2789]). GSE20680, GSE20681 and GSE42148 were downloaded from the Agilent platform (Agilent Technologies, Inc., Santa Clara, CA, USA). Microarray raw data (TXT files) of the three datasets were log2-transformed using Limma 3.34.0 (<https://bioconductor.org/packages/release/bioc/html/limma.html>) to achieve an approximate normal distribution, and were subsequently standardized using the median normalization method ([@b17-mmr-18-03-2789]).

### WGCNA analysis

WGCNA is a well-established method for constructing scale-free gene co-expression networks, which is characterized by the use of soft thresholding ([@b18-mmr-18-03-2789],[@b19-mmr-18-03-2789]). GSE12288 was used as the training dataset, while GSE20680, GSE20681 and GSE42148 were the validations sets. Genes with coefficients of variation \<0.1 were discarded. Correlations between the gene expression in the four datasets were evaluated with the verboseScatterplot function of the WGCNA package (<https://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/>). Weighted gene co-expression networks of the genes in the training dataset were constructed using the WGCNA method as previously described ([@b20-mmr-18-03-2789]--[@b22-mmr-18-03-2789]). First, the soft threshold power of β was set as 18 (scale-free R^2^=0.9), according to the scale free topology criterion. The weighted adjacency matrix was subsequently constructed. Adjacencies and correlations were transformed into a topological overlap matrix (TOM), followed by calculating the corresponding dissimilarity (1-TOM). Subsequently, a hierarchical clustering analysis ([@b23-mmr-18-03-2789]) of genes was performed using 1-TOM as the distance measure. Modules were detected using dynamic tree cut algorithm with a minimum module size of 50 and a minimum cut height of 0.95. Furthermore, module preservation between the training set and the three validation sets was measured using the module preservation function of the WGCNA software package. Possible functions of the preserved module were studied using the user List Enrichment function of the WGCNA package.

### Identification of DEGs with significant consistency in four datasets

DEGs between CAD samples and healthy controls were screened in each of the above four datasets using the metaDE method ([@b10-mmr-18-03-2789],[@b24-mmr-18-03-2789]) in R language (<https://cran.r-project.org/web/packages/MetaDE/>). Heterogeneity was examined across the four datasets to assess the consistency of gene expression, by calculating tau2 and Qpval values. A tau2=0 and Qpval \>0.05 indicated that the gene was homogeneous and unbiased. The thresholds for DEG identification were tau2=0, Qpval \>0.05 and false discovery rate \<0.05. Consistency of the DEGs was detected using the MetaDE method, and the DEGs with significant consistency in the four datasets were selected for further analysis.

### Construction of a PPI network

A PPI network was constructed to evaluate the interactions between genes in the above network. The common genes in the preserved modules that were obtained from WGCNA, and the DEGs with significant consistency, were selected to construct a PPI network based on three databases: The Biological General Repository for Interaction Datasets 3.4.153 (<http://thebiogrid.org/>) ([@b25-mmr-18-03-2789]); the Human Protein Reference Database Release 9 (<http://www.hprd.org/>) ([@b26-mmr-18-03-2789]); and STRING 10.5 (<https://string-db.org/>) ([@b27-mmr-18-03-2789]). The PPIs revealed in at least two of the three databases were extracted for the PPI network, visualized using Cytoscape 3.3 software (<http://www.cytoscape.org/>) ([@b28-mmr-18-03-2789]). In the PPI network, a node represents a gene; the undirected link between two nodes is an edge, denoting the interaction between two genes; and the degree of a node corresponds to the number of interactions of a gene with other genes in the network.

### Gene ontology (GO) functional and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses

In order to elucidate the possible biological roles of the genes in the PPI network, GO ([@b29-mmr-18-03-2789]) functional and KEGG ([@b30-mmr-18-03-2789]) pathway enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery 6.8 software ([@b31-mmr-18-03-2789]). GO terms have three categories, including biological process (BP), cellular compartment and molecular function. P\<0.05 was considered to indicate a significant difference for GO terms and KEGG pathways.

Results
=======

### Identification of key WGCNA modules

Following data preprocessing for the four datasets, the present study attempted to identify CAD-associated co-expression modules using WGCNA. Using the aforementioned methods, the correlation coefficients (CCs) of genes in the four datasets were obtained, and the CCs were 0.47--0.92 with P-values \<1×10^−200^ between any two datasets ([Fig. 1](#f1-mmr-18-03-2789){ref-type="fig"}), suggesting a good consistency of the common genes across all datasets.

As a result, 11 co-expression modules were identified for genes in the training set using WGCNA ([Fig. 2A](#f2-mmr-18-03-2789){ref-type="fig"}). These modules are illustrated in branches of the dendrogram with different colors. To evaluate the robustness of these modules in the training set, the modules were re-constructed in the three validation datasets, GSE20680, GSE20681 and GSE42148, separately ([Fig. 2B-D](#f2-mmr-18-03-2789){ref-type="fig"}). Genes in the three validation sets were colored, according to the module color in the training set. Multi-dimensional scaling of expression data of all genes in these modules demonstrated that genes in the same module appeared to cluster together and exhibited a similar expression pattern ([Fig. 3A](#f3-mmr-18-03-2789){ref-type="fig"}). Additionally, hierarchical clustering analysis of these modules in the four datasets revealed that modules of the same branch tended to have similar gene expression patterns ([Fig. 3B](#f3-mmr-18-03-2789){ref-type="fig"}).

In total, five of the 11 modules, black, brown, magenta, turquoise and yellow modules, with Z-scores \>5 were determined to be well preserved across the four datasets, including 873 genes ([Table II](#tII-mmr-18-03-2789){ref-type="table"}). This suggested that the five highly preserved modules may be closely associated with CAD. Of the five modules, genes in the black module were significantly linked to 'response to glucocorticoid stimulus'; those in the brown module were significantly associated with 'regulation of transcription'; and those in the magenta module may be involved in 'protein localization' ([Table II](#tII-mmr-18-03-2789){ref-type="table"}). Notably, the turquoise and the yellow module exhibited functions in 'immune response' ([Table II](#tII-mmr-18-03-2789){ref-type="table"}).

### Screening for DEGs with significant consistency in the four datasets

Using the metaDE method, 836 DEGs were identified with significant consistency across the four datasets. A heatmap for these DEGs demonstrated that the expression patterns of these DEGs differed between the CAD and control samples ([Fig. 4](#f4-mmr-18-03-2789){ref-type="fig"}).

### Construction of a PPI network for the overlapping genes

A total of 177 genes were overlapping between WGCNA modules and the DEGs with significant consistency ([Fig. 5A](#f5-mmr-18-03-2789){ref-type="fig"}). Of them, 92 genes were included in the turquoise module, 26 in the yellow module, 16 in the black module, 31 in the brown module and 12 in the magenta module ([Fig. 5B](#f5-mmr-18-03-2789){ref-type="fig"}). Based on the three databases mentioned above, a PPI network was built with these overlapping genes. In total, 150 paired PPIs that appeared in at least two of the three databases were included in the PPI network ([Fig. 6A](#f6-mmr-18-03-2789){ref-type="fig"}), which contained 59 downregulated genes and 40 upregulated genes ([Fig. 6B](#f6-mmr-18-03-2789){ref-type="fig"}). All genes in the network were ranked in a descending order, according to their degrees. The top five genes were LCK proto-oncogene, Src family tyrosine kinase (*LCK*; degree=15), euchromatic histone lysine methyltransferase 2 (*EHMT2*; degree=14), inosine monophosphate dehydrogenase 2 (*IMPDH2*; degree=12), protein phosphatase 4 catalytic subunit (*PPP4C*; degree=11) and ζ-chain of T-cell receptor associated protein kinase 70 (*ZAP70*; degree=11).

### Functional annotation

The enrichment analysis indicated that genes in the PPI network were significantly associated with numerous GO BP terms, including the 'transmembrane receptor protein tyrosine kinase signaling pathway' and 'peptidyl-tyrosine autophosphorylation' ([Table III](#tIII-mmr-18-03-2789){ref-type="table"}). With regard to KEGG pathways, there were five significant pathways, including 'metabolic pathways', 'natural killer cell mediated cytotoxicity', 'fructose and mannose metabolism', 'primary immunodeficiency', and 'Fc gamma R-mediated phagocytosis' ([Table IV](#tIV-mmr-18-03-2789){ref-type="table"}). Notably, 'natural killer cell mediated cytotoxicity' and 'primary immunodeficiency' pathways were significantly enriched with *LCK* and *ZAP70*.

Discussion
==========

CAD remains a primary public health concern ([@b32-mmr-18-03-2789]). The present study attempted to dissect the underlying pathogenic mechanisms of CAD via a combined analysis of four GEO datasets, which contained CAD samples and healthy control samples. A total of 11 modules were detected in the WGCNA network, five of which were highly preserved across all datasets. Using the metaDE method, 836 common DEGs in the four datasets were identified. Furthermore, a PPI network was constructed with the 177 overlapping genes of the DEGs with significant consistency and the five preserved WGCNA modules. According to degree, the top five genes of the PPI network were *LCK, EHMT2, IMPDH2, PPP4C* and *ZAP70*. Notably, multiple significant pathways for genes in the PPI network were identified, including 'natural killer cell mediated cytotoxicity', 'primary immunodeficiency', and 'Fc gamma R-mediated phagocytosis' pathways.

The LCK protein encoded by the gene *LCK*, additionally termed lymphocyte-specific protein tyrosine kinase, is a member of the Src family of tyrosine kinases, which are involved in T cell signaling ([@b33-mmr-18-03-2789]). Insufficient deactivation of LCK has been demonstrated to render patients with acute coronary syndrome (ACS) vulnerable to abnormal T cell responses ([@b34-mmr-18-03-2789]). The *ZAP-70* gene encodes the ZAP-70 enzyme, which belongs to the protein-tyrosine kinase family and is a T cell receptor. In T cell signaling, ZAP-70 binds to the CD3 complex that is phosphorylated by the LCK protein ([@b35-mmr-18-03-2789]). It has been established that the ZAP-70 protein expression is able to act as a marker for chronic lymphocytic leukemia or small lymphocytic lymphoma ([@b36-mmr-18-03-2789]).

In the present study, *LCK* (degree=15) and *ZAP70* (degree=11) were highlighted in the PPI network. Furthermore, based on the KEGG pathway enrichment analysis, *LCK* and *ZAP70* were significantly associated with 'natural killer cell mediated cytotoxicity' and 'primary immunodeficiency' pathways, which were associated with immune processes. Similarly, there is evidence that dysregulated adaptive immunity serves a causative role in ACS ([@b37-mmr-18-03-2789]). Therefore, it may be inferred that *LCK* and *ZAP70* serve a role in CAD, which may partly be by regulating natural killer cell mediated cytotoxicity and primary immunodeficiency pathways. Additionally, a previous study with a novel knowledge-based approach revealed that the Fc gamma R-mediated phagocytosis pathway is a pathogenic mechanism for CAD ([@b38-mmr-18-03-2789]). Likewise, the present study suggests that 'Fc gamma R-mediated phagocytosis' may have a function in CAD.

EHMT2, encoded by the gene *EHMT2*, termed G9a, is a histone methyltransferase that serves a critical role in epigenetic regulation within the nucleus accumbens ([@b39-mmr-18-03-2789]). Histone methylation has emerged as a crucial epigenetic mechanism for cardiovascular development and homeostasis ([@b40-mmr-18-03-2789]). Papait *et al* ([@b41-mmr-18-03-2789]) demonstrated that EHMT2 orchestrates important epigenetic alterations in cardiomyocyte homeostasis and hypertrophy. Furthermore, EHMT1/2 has been suggested to be a therapeutic target against pathological cardiac hypertrophy ([@b42-mmr-18-03-2789]). These results are in accordance with the present results, which demonstrated that EHMT2 was a predominant gene in the PPI network (degree=14). These collectively suggest a potentially critical role of EHMT2 in CAD.

IMPDH2, encoded by gene *IMPDH2*, termed IMP dehydrogenase 2, acts as a rate-limiting enzyme in guanine nucleotide biosynthesis ([@b43-mmr-18-03-2789]). It has been reported to be involved in a number of cancer types, including primary nasopharyngeal carcinoma ([@b44-mmr-18-03-2789]) and prostate cancer ([@b45-mmr-18-03-2789]). Nonetheless, the role of IMPDH2 in CAD has been poorly defined. The *PPP4C* gene encodes the PP4C protein, which is a member of the type 2 serine/threonine protein phosphatase family ([@b46-mmr-18-03-2789]), and partly regulates the phosphorylation of numerous proteins implicated in cardiac physiology and hypertrophy ([@b47-mmr-18-03-2789],[@b48-mmr-18-03-2789]). The present study indicated that *IMPDH2* and *PPP4C* may be important genes in CAD.

Although a comprehensive bioinformatics analysis using four datasets was performed, there were a number of limitations. The potentially important genes associated with CAD lacked gene expression and functional validation. Further studies are required with substantial experiments *in vivo* and *in vitro*. Furthermore, the four datasets were not from the same platform, which may cause numerous deviations. Nevertheless, the present study provides novel insight into CAD pathogenesis.

In conclusion, the present study revealed that *LCK, EHMT2, IMPDH2, PPP4C* and *ZAP70* may be proposed as genetic biomarkers for CAD. They may function via the involvement of the 'natural killer cell mediated cytotoxicity', 'primary immunodeficiency', and 'Fc gamma R-mediated phagocytosis pathways' in CAD. These results require further validation with substantial experiments.
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![Correlation analysis of genes in four datasets from the Gene Expression Omnibus database. CC, correlation coefficient.](MMR-18-03-2789-g00){#f1-mmr-18-03-2789}

![Identification of gene co-expression modules. (A) Training set GSE12288, and three validation sets, (B) GSE20680, (C) GSE20681 and (D) GSE42148, were examined. Modules are marked in different colors.](MMR-18-03-2789-g01){#f2-mmr-18-03-2789}

![MDS plot and hierarchical dendrograms of the four datasets. (A) MDS plot of expression data of genes in 11 modules. (B) Hierarchical clustering tree of 11 modules in the four datasets. Modules are denoted via a 'D' and 'M' system: D1, GSE12288; D2, GSE20681; D3, GSE20680; D4, GSE42148; M1, black; M2, dark blue; M3, brown; M4, green; M5, grey; M6, magenta; M7, red; M8, pink; M9, turquoise; M10, yellow; and M11, purple. MDS, multi-dimensional scaling.](MMR-18-03-2789-g02){#f3-mmr-18-03-2789}

![Heatmap of hierarchical clustering of differentially expressed genes with significant consistency, identified using the metaDE method. CAD and normal samples notably differed from each other with respect to gene expression patterns. CAD, coronary artery disease.](MMR-18-03-2789-g03){#f4-mmr-18-03-2789}

![Analysis of overlapping genes. (A) Venn diagram of the overlapping genes between WGCNA modules (green) and the genes with significant consistency identified using MetaDE (pink). (B) Numbers of overlapping genes in each of the five highly preserved WGCNA modules. WGCNA, weighted gene co-expression network.](MMR-18-03-2789-g04){#f5-mmr-18-03-2789}

![Construction of the PPI network. (A) Venn diagram of PPIs obtained from BioGRID, HPRD Release 9 and STRING. (B) PPI network. A red triangle denotes an upregulated gene and a green inverted triangle denotes a downregulated gene. The top five genes with higher degrees compared with the other genes in the network are represented by five extra-large green inverted triangles, separately. PPI, protein-protein interaction; BioGRID, Biological General Repository for Interaction Datasets; HPRD, Human Protein Reference Database; LCK, LCK proto-oncogene, Src family tyrosine kinase; EHMT2, euchromatic histone lysine methyltransferase 2; IMPDH2, inosine monophosphate dehydrogenase 2; PPP4C, protein phosphatase 4 catalytic subunit; ZAP70, ζ-chain of T-cell receptor associated protein kinase 70.](MMR-18-03-2789-g05){#f6-mmr-18-03-2789}

###### 

Information on the four Gene Expression Omnibus datasets.

  Accession no.   Platform   Probe no.   Total sample no.   CAD   Control
  --------------- ---------- ----------- ------------------ ----- ---------
  GSE12288        GPL96      22283       222                112   110
  GSE20680        GPL4133    45220       139                87    52
  GSE20681        GPL4133    45220       198                99    99
  GSE42148        GPL13607   62976       24                 13    11

CAD, coronary artery disease.

###### 

Characteristics of weighted gene co-expression network modules.

  Dataset   Characteristic                                             
  --------- ---------------- ------- ------- ----------- ----- ------- --------------------------------------------------
  D1M1      D2M1             D3M1    D4M1    Black       85    13.81   Response to glucocorticoid stimulus
  D1M2      D2M2             D3M2    D4M2    Blue        285   0.58    Humoral immune response
  D1M3      D2M3             D3M3    D4M3    Brown       211   5.26    Regulation of transcription
  D1M4      D2M4             D3M4    D4M4    Green       121   0.16    Regulation of transcription
  D1M5      D2M5             D3M5    D4M5    Grey        572   3.92    Defense response
  D1M6      D2M6             D3M6    D4M6    Magenta     51    5.66    Protein localization
  D1M7      D2M7             D3M7    D4M7    Red         68    0.63    Cell surface receptor linked signal transduction
  D1M8      D2M8             D3M8    D4M8    Pink        108   1.31    Second-messenger-mediated signaling
  D1M9      D2M9             D3M9    D4M9    Turquoise   400   14.34   Immune response
  D1M10     D2M10            D3M10   D4M10   Yellow      126   12.54   Immune response
  D1M11     D2M11            D3M11   D4M11   Purple      50    1.35    Lymphocyte activation

###### 

Significant GO terms.

  Category             Term                                                               Count of genes   P-value
  -------------------- ------------------------------------------------------------------ ---------------- ---------
  Biology process      Transmembrane receptor protein tyrosine kinase signaling pathway   9                \<0.001
                       Peptidyl-tyrosine autophosphorylation                              5                \<0.001
                       Oxidation-reduction process                                        13               \<0.001
                       Inflammatory response                                              10               \<0.001
                       Mesoderm development                                               4                \<0.001
                       Innate immune response                                             9                0.003
                       Carbohydrate phosphorylation                                       3                0.007
                       Regulation of defense response to virus by virus                   3                0.011
                       Chromatin remodeling                                               4                0.013
                       Response to lipopolysaccharide                                     5                0.014
                       Protein autophosphorylation                                        5                0.017
                       Peptidyl-lysine modification to peptidyl-hypusine                  2                0.022
                       Lymphocyte proliferation                                           2                0.028
                       Fc-gamma receptor signaling pathway involved in phagocytosis       4                0.035
                       Response to fungicide                                              2                0.039
                       Negative regulation of B cell activation                           2                0.039
                       Apoptotic process                                                  8                0.042
  Cellular component   Extrinsic component of cytoplasmic side of plasma membrane         5                0.000
                       Ruffle                                                             4                0.012
                       Protein phosphatase 4 complex                                      2                0.021
                       Neuron projection                                                  5                0.038
  Molecular function   Protein tyrosine kinase activity                                   5                0.007
                       Kinase activity                                                    6                0.013
                       Insulin receptor binding                                           3                0.014
                       Electron carrier activity                                          4                0.015
                       Cholestenone 5-alpha-reductase activity                            2                0.017
                       Catalytic activity                                                 5                0.023
                       Poly(A) RNA binding                                                13               0.028
                       Oxidoreductase activity                                            5                0.028
                       mRNA 3′-untranslated region binding                                3                0.032
                       Receptor activity                                                  5                0.037
                       Enzyme binding                                                     6                0.043

Count of genes represents the number of genes significantly enriched in each GO term. GO, gene ontology.

###### 

Significant KEGG signaling pathways.

  Term                                        Count   P-value   Genes
  ------------------------------------------- ------- --------- ------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolic pathways                          22      0.001     GCDH, CES1, GNE, AMACR, SPHK1, PISD, CKB, GCH1, ALDH1A1, ADI1, HK3, NT5C2, AKR1B1, SMPD1, MBOAT2, CDA, CYP4F3, ACSL4, PCYT2, IMPDH2, CBS, AOC3
  Natural killer cell mediated cytotoxicity   5       0.022     PRF1, LCK, ZAP70, PAK1, FAS
  Fructose and mannose metabolism             3       0.032     PFKFB4, HK3, AKR1B1
  Primary immunodeficiency                    3       0.036     CD8B, LCK, ZAP70
  Fc gamma R-mediated phagocytosis            4       0.038     HCK, SPHK1, PAK1, CRK

Count of genes denotes the number of genes significantly associated with each KEGG pathway. KEGG, Kyoto Encyclopedia of Genes and Genomes.
